Prezcobix and Ranitidine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Prezcobix (cobicistat; darunavir ethanolate) and Ranitidine (ranitidine). Common drug interactions include anaemia among females and pain among males.

The phase IV clinical study analyzes what interactions people have when they take Prezcobix and Ranitidine. It is created by eHealthMe based on reports of 66 people who take the same drugs from the FDA, and is updated regularly.

What is Prezcobix?

Prezcobix has active ingredients of cobicistat; darunavir ethanolate. eHealthMe is studying from 2,113 Prezcobix users. Check the latest studies of Prezcobix.

What is Ranitidine?

Ranitidine has active ingredients of ranitidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 234,475 Ranitidine users. Check the latest studies of Ranitidine.



On Jun, 14, 2026

66 people who take Prezcobix and Ranitidine together, and have interactions are studied.

Prezcobix and Ranitidine drug interactions.

What are the common drug interactions of Prezcobix and Ranitidine, by gender? *:

female:

  1. Anaemia (lack of blood)
  2. Ankle fracture
  3. Foot fracture
  4. General physical health deterioration (weak health status)
  5. Hyperkalaemia (damage to or disease of the kidney)
  6. Hypertension (high blood pressure)
  7. Osteonecrosis (death of bone)
  8. Osteopenia (a condition where bone mineral density is lower than normal)
  9. Pneumonia
  10. Renal impairment (severely reduced kidney function)

male:

  1. Pain
  2. Emotional distress
  3. Osteopenia (a condition where bone mineral density is lower than normal)
  4. Osteonecrosis (death of bone)
  5. Arthralgia (joint pain)
  6. Renal impairment (severely reduced kidney function)
  7. Hip fracture
  8. Nausea (feeling of having an urge to vomit)
  9. Diarrhoea
  10. Hand fracture

What are the common drug interactions of Prezcobix and Ranitidine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Anxiety
  2. Emotional distress
  3. Pain
  4. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  5. Chronic kidney disease
  6. Renal failure (kidney dysfunction)
  7. Tooth loss
  8. Asthenia (weakness)
  9. Osteopenia (a condition where bone mineral density is lower than normal)
  10. Anaemia (lack of blood)

30-39:

  1. Osteonecrosis (death of bone)
  2. Anxiety
  3. Bone density decreased
  4. Emotional distress
  5. Pain
  6. Arthralgia (joint pain)
  7. Depression
  8. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  9. Hip fracture
  10. Osteoporosis (bones weak and more likely to break)

40-49:

  1. Surgery
  2. Vomiting
  3. Asthenia (weakness)
  4. Facial bones fracture (bone fracture of face)
  5. Foot fracture
  6. Fracture
  7. Gait disturbance
  8. Multiple fractures
  9. Musculoskeletal disorder (disease of the body's muscles, joints, tendons, ligaments and nerves)
  10. Nephropathy (damage to or disease of a kidney)

50-59:

  1. Pain
  2. Emotional distress
  3. Anxiety
  4. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  5. Bone density decreased
  6. Osteoporosis (bones weak and more likely to break)
  7. Multiple fractures
  8. Osteopenia (a condition where bone mineral density is lower than normal)
  9. Depression
  10. Fracture

60+:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
  4. Osteopenia (a condition where bone mineral density is lower than normal)
  5. Osteoporosis (bones weak and more likely to break)
  6. Pain
  7. Pain in extremity
  8. Pain in jaw
  9. Platelet count decreased
  10. Quality of life decreased

What are the existing conditions these people have? *

  1. Hiv Infection: 59 people, 89.39%
  2. Pain: 9 people, 13.64%
  3. Nausea (feeling of having an urge to vomit): 7 people, 10.61%
  4. Bacterial Infection: 7 people, 10.61%
  5. Asthma: 7 people, 10.61%
  6. Depression: 6 people, 9.09%
  7. Stress And Anxiety: 5 people, 7.58%
  8. Hypersensitivity: 5 people, 7.58%
  9. High Blood Pressure: 5 people, 7.58%
  10. Diabetes: 5 people, 7.58%

* Approximation only. Some reports may have incomplete information.

Do you take Prezcobix and Ranitidine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Prezcobix and Ranitidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Prezcobix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ranitidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Prezcobix and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ranitidine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cobicistat; darunavir ethanolate and ranitidine (the active ingredients of Prezcobix and Ranitidine, respectively), and Prezcobix and Ranitidine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: